HBV - Hepatocellular Cardinoma

Does Previous Hepatitis B Exposure Increase Liver Cancer Risk?
12-14-2010

Alcohol and Diabetes Increase Risk of Liver Disease Progression in Hepatitis B Patients
12-03-2010

Androgen Receptor May Explain Why More Men with Hepatitis B Develop Liver Cancer
9-21-2010

CDC Reports Increasing Incidence of Liver Cancer, Mostly Due to Chronic Hepatitis B and C
6-15-2010

Sex Hormone Receptor May Explain Higher Risk of Hepatocellular Carcinoma in Men
6-11-2010

Parenchymal Fibrosis and Cancer Specific Outcomes Following Liver Resection in Patients with HBV Associated Hepatocellular Carcinoma
11/03/09

Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients with Evidence of Hepatic Decompensation
11/03/09

Factors Associated with Development of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
6-2-2009

Meta-analysis Shows Interferon Reduces Progression to Cirrhosis and Liver Cancer in People with Chronic Hepatitis B
4/03/09

Chronic Hepatitis B Patients May Need to Begin Liver Cancer Screening at a Younger Age than Currently Recommended
3/27/09

Variables Impacting Treatment and Prognosis in Young Patients (under Age 40) who Develop Hepatitis B Virus-Associated Hepatocellular Carcinoma; Implications for Management of an Unscreened Population
3/27/09

Hepatitis Delta Increases the Risk of Liver Cirrhosis and Hepatocellular Carcinoma in People with Hepatitis B
2/24/2009

European Association for the Study of the Liver (EASL) Publishes First Guidelines for Management of Chronic Hepatitis B
2/03/2009

Final Statement from Consensus Development Conference on Management of Hepatitis B
1/13/2009

FDA-approved Therapies for Chronic HBV Infection Baraclude  (entecavir) Epivir-HBV  (lamivudine; 3TC) Hepsera   (adefovir dipivoxil) Intron A  (interferon alfa-2b) Pegasys  (peginterferon alfa-2a) Viread  (tenofovir) Tyzeka   (telbivudine)

Experimental Treatments